Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumor cell-specific responsive self-assembling drug nanoconjugate

Tumor cell-specific responsive self-assembling drug nanoconjugate

US Patent 10610602 · Granted Apr 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic compounds for red blood cell-mediated delivery of an active pharmace2024
Optical modulation device and phase modulation method using the same2024
Therapeutic compounds for red blood cell-mediated delivery of an active pharmace2024
Method for inducing trans-differentiation of cardiomyocytes based on exosome2024
Visible light-activatable nanoparticles for cancer immunotherapy and use thereof2023
Probe for measuring activity of Caspase-1 and composition for diagnosis of infla2023
Method of treating cancer by using siRNA nanocomplexes2023
Pharmaceutical composition for combination therapy for preventing or treating ca2022
Immunoregulatory protein-siRNA complex having anticancer activity2022
Immunoregulatory protein-siRNA complex having anticancer activity2022
Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite2021
Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite2021